The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
John Tlumacki | Boston Globe | Getty Images
DocuSign – Shares of the electronic signature company surged 19.7% after beating on the top and bottom lines of its quarterly earnings. DocuSign earned 44 cents per share on revenue of $469 million. Analysts expected earnings of 28 cents per share on revenue of $438 million, according to Refinitiv. DocuSign also gave second-quarter and full-year revenue guidance above estimates.